1283090-74-3 Usage
Explanation
Different sources of media describe the Explanation of 1283090-74-3 differently. You can refer to the following data:
1. The compound consists of 20 carbon atoms, 16 hydrogen atoms, 1 chlorine atom, 1 fluorine atom, 1 nitrogen atom, and 3 oxygen atoms.
2. The sum of the atomic weights of all the atoms in the compound is approximately 369.8 grams per mole.
3. The compound has a spiro linkage connecting the benzene and piperidine rings, which is characteristic of spiro compounds.
4. The compound contains a benzene ring and a furo[3,4-c]pyridine moiety, both of which are aromatic rings.
5. The compound contains a chlorine atom at position 6 and a fluorine atom at position 7, which are halogen elements.
6. The compound has a piperidine ring, which is a common pharmacophore in many drug molecules.
7. The presence of the piperidine ring and the unique spiro structure may contribute to the compound's pharmacological properties, making it a potentially interesting target for medicinal chemistry research.
8. The compound consists of a benzene ring and a piperidine ring connected through a spiro linkage, with a furo[3,4-c]pyridine moiety attached to the piperidine ring, and a chlorine atom at position 6 and a fluorine atom at position 7.
Molecular weight
369.8 g/mol
Spiro compound
Yes
Aromatic rings
2 (benzene and furo[3,4-c]pyridine)
Presence of halogens
Yes (chlorine and fluorine)
Presence of a piperidine ring
Yes
Potential pharmaceutical relevance
High
Chemical structure
1'-benzyl-6-chloro-7-fluoro-1H-spiro[furo[3,4-c]pyridine-3,4'-piperidin]-1-one
Check Digit Verification of cas no
The CAS Registry Mumber 1283090-74-3 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,8,3,0,9 and 0 respectively; the second part has 2 digits, 7 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 1283090-74:
(9*1)+(8*2)+(7*8)+(6*3)+(5*0)+(4*9)+(3*0)+(2*7)+(1*4)=153
153 % 10 = 3
So 1283090-74-3 is a valid CAS Registry Number.
1283090-74-3Relevant articles and documents
DIARYLMETHYLAMIDE DERIVATIVE HAVING MELANIN-CONCENTRATING HORMONE RECEPTOR ANTAGONISM
-
, (2011/04/24)
The present invention is directed to diarylmethylamide derivatives represented of structural formula I which are melanin-concentrating hormone receptor antagonists, and are useful as an agent for the prevention, treatment, or remedy of various circulatory diseases, neurological diseases, metabolic diseases, reproductive system diseases, respiratory diseases, digestive diseases, and the like. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which the melanin-concentrating hormone is involved. I
